Black Rock Inc. Ovid Therapeutics Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,195,289 shares of OVID stock, worth $3.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,195,289

Previous 4,319,918 2.88%

Holding current value

$3.23 Million

Previous $13.9 Million 8.02%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$2.72 - $4.04 $338,990 - $503,501	-124,629 Reduced 2.88%	4,195,289 $12.8 Million
Q4 2023 Feb 13, 2024	BUY	$2.98 - $3.78 $2.38 Million - $3.02 Million	799,574 Added 22.71%	4,319,918 $13.9 Million
Q3 2023 Nov 13, 2023	BUY	$3.23 - $3.97 $362,202 - $445,183	112,137 Added 3.29%	3,520,344 $13.5 Million
Q2 2023 Aug 11, 2023	BUY	$2.53 - $3.89 $6.79 Million - $10.4 Million	2,682,320 Added 369.52%	3,408,207 $11.2 Million
Q1 2023 May 12, 2023	BUY	$1.88 - $2.85 $6,219 - $9,427	3,308 Added 0.46%	725,887 $1.87 Million

Q4 2022 Feb 13, 2023	SELL	$1.43 - $1.86 $622,301 - $809,427	-435,176 Reduced 37.59%	722,579 $1.34 Million
Q3 2022 Nov 14, 2022	SELL	$1.85 - $2.26 $32,312 - $39,473	-17,466 Reduced 1.49%	1,157,755 $2.13 Million
Q2 2022 Aug 12, 2022	BUY	$1.69 - $3.31 $38,721 - $75,838	22,912 Added 1.99%	1,175,221 $2.53 Million
Q1 2022 May 12, 2022	BUY	$2.65 - $3.49 $11,739 - $15,460	4,430 Added 0.39%	1,152,309 $3.62 Million
Q4 2021 Feb 10, 2022	SELL	$3.13 - $3.73 $16,153 - $19,250	-5,161 Reduced 0.45%	1,147,879 $3.68 Million
Q3 2021 Nov 09, 2021	SELL	$3.31 - $4.04 $164,473 - $200,747	-49,690 Reduced 4.13%	1,153,040 $3.88 Million
Q2 2021 Aug 11, 2021	BUY	$3.3 - $4.49 $3.97 Million - $5.4 Million	1,202,730 New	1,202,730 $4.7 Million

Others Institutions Holding OVID

# of Institutions

Shares Held

43.2M

Call Options Held

5.9K

Put Options Held

300

View Full List

About Ovid Therapeutics Inc.

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $54.2M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

More about OVID

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account